T
TideTron
Synthetic biology platform for mass-producing various substances
About TideTron
Tichuang Bio (also known as Tidetron Bioworks Technology Co., Ltd.) is a synthetic biology company founded in 2021 by Dr. Zhiqian Zhang. The company operates a biomanufacturing platform for the mass production of a wide range of substances. It has developed the Tidetron Altra platform, which includes a proprietary strain and component library, along with the iTidetron AI engine, to streamline the research, development, and production cycle.
The company's business model is centered on providing integrated solutions, from research and development to large-scale manufacturing, for various industries. Tichuang Bio serves clients in sectors such as skin care, food and beverage, household cleaning, and biomedicine. Revenue is generated through the sale of over 30 existing raw materials, including peptides and erythritol, and by offering customized production services. The firm operates an intelligent factory in Jinan, Shandong Province, with an annual production capacity exceeding 10,000 tons, utilizing advanced fermentation and purification technologies.
A key focus for the company is sustainable and environmentally friendly production. Its processes are designed for low energy consumption, reduced pollution, and low carbon emissions. For instance, their bio-peptide production process reportedly reduces emissions by up to 95%. The company also engages in developing biodegradable materials, such as all-bio-based Polybutylene Succinate (PBS), to support plastic reduction goals. Tichuang Bio collaborates with academic institutions like Sun Yat-sen University and Jiangnan University to further the integration of industry, academia, and research in synthetic biology.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Guangzhou, China
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 30.3/100
- Industry
- Health, Chemicals
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Green Chemical, Synthetic Biology, Sustainable Development Goals, Fermentation, Climate Tech, Peptides, biomanufacturing, DT and LS, science-based
- Business model
- Manufacturing
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Mar 2022 | $100M | $400M | Legend Capital · IDG Capital | ↗ |
Growth signals
Latest recorded traffic for TideTron is 320 monthly website visits, down 3% over the last three months. TideTron's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TideTron on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TideTron’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.